| 0.9 |
3.5 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.8 |
4.9 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.7 |
24.9 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.7 |
3.3 |
GO:0044854 |
membrane raft assembly(GO:0001765) nitric oxide homeostasis(GO:0033484) negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 0.6 |
3.4 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.6 |
2.8 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.5 |
3.0 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.4 |
2.0 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.4 |
3.2 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.3 |
2.8 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.3 |
1.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 |
2.3 |
GO:0030007 |
cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
| 0.3 |
0.6 |
GO:1903707 |
negative regulation of myeloid cell differentiation(GO:0045638) negative regulation of hemopoiesis(GO:1903707) |
| 0.3 |
1.5 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.2 |
3.2 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.2 |
0.7 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.2 |
11.6 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.2 |
0.6 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.2 |
1.0 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
0.6 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.2 |
1.9 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.2 |
2.6 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.2 |
1.4 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.2 |
3.1 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.2 |
1.5 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 |
2.0 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.2 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
2.9 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
2.2 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.1 |
0.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.7 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
2.4 |
GO:0071333 |
cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
| 0.1 |
0.5 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.1 |
0.9 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 |
0.4 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 |
0.5 |
GO:1902414 |
protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.1 |
1.0 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.8 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.3 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.4 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
2.6 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.1 |
1.0 |
GO:0021955 |
central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
| 0.1 |
0.3 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.2 |
GO:0031558 |
obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
| 0.1 |
0.3 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.1 |
0.6 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.1 |
1.3 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
1.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
2.9 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 |
0.3 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.1 |
0.6 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.1 |
6.1 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.1 |
0.3 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
0.2 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
2.2 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
1.7 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.1 |
0.5 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
3.2 |
GO:0050931 |
melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.1 |
2.1 |
GO:0051925 |
obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.1 |
0.2 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 |
0.7 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
0.2 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.1 |
0.5 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.4 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.1 |
1.4 |
GO:0001960 |
negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
| 0.1 |
0.4 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.3 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
1.6 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
| 0.1 |
0.6 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.1 |
0.1 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
1.0 |
GO:0034405 |
response to fluid shear stress(GO:0034405) |
| 0.1 |
1.2 |
GO:0042325 |
regulation of phosphorylation(GO:0042325) |
| 0.1 |
0.8 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.2 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.1 |
0.6 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
0.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
1.7 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.1 |
0.2 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.2 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
0.2 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.1 |
3.3 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.1 |
0.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.1 |
0.3 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.1 |
1.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.1 |
GO:0070244 |
negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.1 |
0.2 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
| 0.1 |
0.7 |
GO:0045445 |
myoblast differentiation(GO:0045445) |
| 0.1 |
0.8 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.4 |
GO:0060666 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.2 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.1 |
0.1 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.3 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 |
0.2 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.0 |
0.4 |
GO:0010799 |
regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.1 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.0 |
2.6 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.2 |
GO:0051130 |
positive regulation of cellular component organization(GO:0051130) |
| 0.0 |
1.4 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.2 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.2 |
GO:0060999 |
positive regulation of dendritic spine development(GO:0060999) positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
0.2 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.0 |
0.4 |
GO:1903307 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) positive regulation of regulated secretory pathway(GO:1903307) |
| 0.0 |
0.1 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
0.7 |
GO:0015800 |
acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
| 0.0 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.7 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.0 |
0.1 |
GO:0001807 |
type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.0 |
0.3 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.1 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.3 |
GO:0070498 |
response to peptidoglycan(GO:0032494) interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.8 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.2 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.3 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.0 |
0.1 |
GO:0002331 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.0 |
0.5 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.0 |
0.6 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.4 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
1.1 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.2 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.2 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
0.4 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
2.5 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.2 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.3 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
1.5 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.0 |
0.2 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.1 |
GO:2000644 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
| 0.0 |
0.1 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
0.2 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.1 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
0.2 |
GO:0009136 |
ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.0 |
0.1 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.0 |
0.3 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.2 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.1 |
GO:0006591 |
ornithine metabolic process(GO:0006591) regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.0 |
0.3 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.2 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.0 |
1.1 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
| 0.0 |
0.1 |
GO:0015802 |
basic amino acid transport(GO:0015802) |
| 0.0 |
0.3 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
| 0.0 |
0.1 |
GO:0034243 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.3 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.0 |
0.1 |
GO:1903301 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.5 |
GO:0046464 |
triglyceride catabolic process(GO:0019433) neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.0 |
0.0 |
GO:0001845 |
phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
| 0.0 |
0.1 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.7 |
GO:0034329 |
cell junction assembly(GO:0034329) cell junction organization(GO:0034330) |
| 0.0 |
0.1 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.5 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.0 |
0.3 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.2 |
GO:0061756 |
leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
0.7 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.3 |
GO:0007507 |
heart development(GO:0007507) |
| 0.0 |
0.5 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
1.3 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.3 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.0 |
1.1 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.0 |
0.9 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.3 |
GO:2000060 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) negative regulation of ubiquitin protein ligase activity(GO:1904667) regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
1.4 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.4 |
GO:0008544 |
epidermis development(GO:0008544) |
| 0.0 |
0.2 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.0 |
0.6 |
GO:0030307 |
positive regulation of cell growth(GO:0030307) |
| 0.0 |
0.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.4 |
GO:0071822 |
protein complex subunit organization(GO:0071822) |
| 0.0 |
0.1 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.0 |
0.6 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.1 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.4 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.0 |
0.3 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.0 |
2.9 |
GO:0007015 |
actin filament organization(GO:0007015) |
| 0.0 |
1.1 |
GO:0007601 |
visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
| 0.0 |
0.3 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.0 |
0.1 |
GO:0000098 |
sulfur amino acid catabolic process(GO:0000098) |
| 0.0 |
0.1 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.0 |
0.1 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 |
0.2 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.1 |
GO:0045184 |
establishment of protein localization(GO:0045184) |
| 0.0 |
0.6 |
GO:0050920 |
regulation of chemotaxis(GO:0050920) |
| 0.0 |
0.2 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
2.0 |
GO:0006936 |
muscle contraction(GO:0006936) |
| 0.0 |
0.3 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.1 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
1.0 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
1.6 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.0 |
0.1 |
GO:0060322 |
brain development(GO:0007420) head development(GO:0060322) |
| 0.0 |
0.1 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.0 |
0.8 |
GO:0006986 |
response to unfolded protein(GO:0006986) |
| 0.0 |
0.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.4 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
0.0 |
GO:1902170 |
response to nitric oxide(GO:0071731) cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
